– USA, NY – Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics, today announced the appointments to its Board of Directors of:
- Dr. Sean Ianchulev, Director, CEO, and CMO appointed Chairman
- Kenneth Lee, Jr., Director, named Lead Director
- Rachel Jacobson appointed to the Board
- Stephen Benjamin appointed to the Board
The company also announced the retirement of Dr. Ernest Mario from the Board, effective immediately.
“I would like to thank Dr. Mario for his enormous and instrumental role in the foundation of our OpteJet technology. He has been involved almost since its very inception ten years ago,” said Dr. Ianchulev. “I also would like to welcome Rachel and Stephen to the Board. They will bring expertise and insights which will greatly enrich our perspective as we move the company forward towards the commercial stage. Both Rachel and Stephen bring a track record of leadership across a diverse range of industries, and I look forward to their insights and guidance.”
About Rachel Jacobson
Rachel Jacobson brings to the Board significant expertise in business development and marketing, having spent 21 years with the National Basketball Association, where she oversaw business development, licensing, marketing, account management, and event planning, among other roles. Currently, she serves as the President of the Drone Racing League, where she spearheads global partnerships and media rights deals, and leads the marketing and business development teams, bringing to DRL her legacy of creating transformative partnerships with leading sports and technology brands. As the SVP of Global Partnerships at the National Basketball Association, she closed partnership sales and secured global partnerships with some of the world’s most prominent companies, including PepsiCo, ExxonMobil, Under Armour, Marriott, Harman, Kaiser Permanente, and other Fortune 500 companies. Before DRL, she also served as the Chief Business Development Officer at Landit, the market leader in personalized career pathing technology to increase the success and engagement of women and diverse groups in the workplace. Ms. Jacobson is a graduate of the Cornell University School of Hotel & Business Management.
About Stephen Benjamin
Stephen Benjamin is an attorney with a track record of leadership in government and the public sector. He was elected Mayor of Columbia, South Carolina in April of 2010. He served three successful terms as Mayor concluding in December of 2021. Before he served as mayor, Mr. Benjamin: served in South Carolina Governor Jim Hodges’ Cabinet as the CEO of a 950 employee state agency; served as special counsel at a national law firm; served on the Board of Directors, Audit & CRA Committees of a financial institution; served on the Board of Directors of an NYSE traded financial services company, and served on the Board of Trustees of a not for profit hospital. Mr. Benjamin has served as President of the U.S. Conference of Mayors (2018-2019), President of the African American Mayors Association, Vice Chairman of the Global Parliament of Mayors, Executive Chairman of Municipal Bonds for America, and as a Member of the Federal Communications Commission’s Intergovernmental Advisory Committee. Mr. Benjamin is a graduate of the University of South Carolina and the University of South Carolina School of Law. Mr. Benjamin is a Principal in The Benjamin Firm, LLC and Of Counsel at The Charleston Group, where he co-chairs the firm’s Public Finance & Affordable Housing Practices.
About Eyenovia, Inc.
Eyenovia, Inc. is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia, and myopia progression.
For more information: https://eyenovia.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
